COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

VTE Prophylaxis After THA for Asian Population: Pharmacological Prop…

Arthroplasty Society in Asia

M. Mihara

VTE Prophylaxis After THA: Chinese Experience

Arthroplasty Society in Asia

H. Cai

VTE Prophylaxis After THA in the Asians: Messages from 2019 AP VTE C…

Arthroplasty Society in Asia

A. Tanavalee

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

Acute DVT: When to and When Not to Intervene?

Venous Edge

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

James Douketis

The Echo Report: More Than Just an EF

Michigan Medicine

S. Kohnstamm

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Cancer-Associated Thrombosis: Anticoagulant Dose and Duration Consid…

BMFcases

T. Bat, M. Carrier

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for …

Keck School of Medicine of USC

L. Clavijo

Catheter Wars: The Thrombus Strikes Back

AVA 2022 Annual Scientific Meeting

A. Bulmer, P. Carr

Assessment of Aortic Regurgitation in the Current Era

Houston Methodist DeBakey Heart and Vascular Center

W. Zoghbi

Thrombus Extending into the IVC

Venous Symposium

P. Muck

Tricuspid TEER: Shortcuts & Simplifications for the Interventionalis…

Scottsdale Interventional Forum 2023

J. Mccabe

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

Aortic Challenges: Acute Type A Aortic Dissection with Malperfusion

Houston Methodist DeBakey Heart and Vascular Center

R. Reul, J. Hong, T. MacGillivray, O. Preventza, F. Veith

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis